# LumenAI Version 1.0 — Operational Excellence Report

LPR-DIR-018 · Operational Excellence Program Phase 7 · Production Launch, Hypercare &
Continuous Improvement · Baseline `451a0b9`. **Documentation/assessment only — no code
modified.**

## 1. Executive summary — the honest premise correction
This directive asks the organization to validate the **operational execution of a
production launch**. **No production launch has occurred, and none is authorized.**
The immediately preceding phase (LPR-DIR-017) certified LumenAI v1.0 as **RELEASE
CANDIDATE — GO WITH CONDITIONS** and **explicitly withheld production and clinical
authorization** pending **1 CRITICAL + 8 HIGH** blocking conditions that remain open.

Consequently there is **no live environment, no tenants, no incidents, no uptime, no
tickets, and no adoption** to measure — and this report **does not fabricate any of
those metrics**. Every production-KPI field across the Phase 7 deliverables is marked
**NOT AVAILABLE — not launched**. What is delivered instead is honest: (a) the
launch/hypercare/KPI/customer/change frameworks with true readiness status, and (b) a
sequenced **Continuous Improvement backlog** that converts six phases of real evidence
into the concrete path to a launch.

## 2. Production health
**PRE-LAUNCH — not in production.** Design-verified strengths only (frozen
architecture, 3,696 tests, 0 CVEs, immutable audit/evidence, DR RTO 10.4 s). No
production health exists to report. (`PRODUCTION_LAUNCH_REPORT.md`.)

## 3. Operational KPIs
**NOT AVAILABLE (not launched).** Only non-production measurements exist (in-process
latency; test-verified audit/evidence; DR RTO). SLOs + the metrics to measure them are
**not yet built** (MON-01, OPS-OBS-01/02). (`OPERATIONS_KPI_REPORT.md`.)

## 4. Hypercare summary
**No hypercare period** — it can only follow a launch, and the detection/response
capabilities it depends on (alerting, IR, on-call) **do not exist** (OPS-INC-01).
(`HYPERCARE_REPORT.md`.)

## 5. Customer success
**No production customers.** Enablement assets (onboarding, training, admin docs) exist
and are real; adoption/tickets/satisfaction are **NOT AVAILABLE**. Product-critical
guardrail: onboarding must disclose "not a trained CV model / no diagnostic claim /
mandatory human review." (`CUSTOMER_SUCCESS_REPORT.md`.)

## 6. Change management
**Code change-control is production-grade** (PR gates + architecture freeze + versioned
GHCR releases); **operational** change processes are missing — deploy is a stub +
no rollback drill (CM-02/OPS-DEP-01/02, blocking), no patch/hotfix runbook, no
maintenance windows, no prod approval gate. (`CHANGE_MANAGEMENT_REVIEW.md`.)

## 7. Continuous improvement
A prioritized backlog seeded from real findings: **7 P0 launch-blockers**, P1 hardening
(audit atomicity, dataset-freeze, dedup, observability, manifests, non-root, IaC,
governance), P2 maintainability/performance (god-module, duplication, N+1, worker
offload, startup, retention), P3 CI automation. Feature/customer requests: **none
(no launch)**. (`CONTINUOUS_IMPROVEMENT_BACKLOG.md`.)

## 8. Final scorecards (carried from Phase 6; operational reality)
Executive aggregate **~3.1/5** ("engineering-complete, production-hardening pending").
Operations maturity **~2.4/5**; Incident Response **1/5**. **Operational-launch
readiness: not met.**

## 9. Executive recommendation
**Do not launch.** Execute the Phase-6 hardening cycle (7 P0 items), stand up
operational capabilities (alerting, IR/on-call, deploy/rollback automation + drill, HA
+ load test), then re-certify (security re-test + passed load test) and run a small
**supervised** production pilot with hypercare capability in place. Only then measure
real KPIs and begin genuine continuous improvement. **No production or clinical
deployment, no new features, and no architectural change are authorized.**

## 10. Operational decision (honest)
The directive's three exit options — **PRODUCTION STABLE / PRODUCTION STABLE WITH
IMPROVEMENTS / PRODUCTION RECOVERY REQUIRED** — **all presuppose a live production
system and therefore none applies.** The truthful determination is:

### 🔻 NOT LAUNCHED — PRODUCTION LAUNCH GATED (none of the three states apply)

The platform is **pre-launch**, not "stable" (it never launched) and not "recovery
required" (nothing is broken in production because there is no production). A
"PRODUCTION STABLE" verdict cannot be issued without a production system and would be a
fabrication. The correct next action is the hardening cycle above, **not** operating a
launch that has not occurred.
